These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 12884331

  • 1. Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations.
    Kanematsu M, Semelka RC, Leonardou P, Mastropasqua M, Lee JK.
    J Magn Reson Imaging; 2003 Aug; 18(2):189-95. PubMed ID: 12884331
    [Abstract] [Full Text] [Related]

  • 2. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 3. MR imaging of hepatocellular carcinomas with biliary tumor thrombi.
    Gabata T, Terayama N, Kobayashi S, Sanada J, Kadoya M, Matsui O.
    Abdom Imaging; 2007 Oct; 32(4):470-4. PubMed ID: 17151901
    [Abstract] [Full Text] [Related]

  • 4. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
    Kemmer N, Neff G, Kaiser T, Zacharias V, Thomas M, Tevar A, Satwah S, Shukla R, Buell J.
    Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM.
    Hepatogastroenterology; 2009 Oct; 56(94-95):1417-24. PubMed ID: 19950803
    [Abstract] [Full Text] [Related]

  • 6. Small hyperintense hepatic lesions on T1-weighted images in patients with cirrhosis: evaluation with serial MRI and imaging features for clinical benignity.
    Shimizu A, Ito K, Sasaki K, Hayashida M, Tanabe M, Shimizu K, Matsunaga N.
    Magn Reson Imaging; 2007 Dec; 25(10):1430-6. PubMed ID: 17524587
    [Abstract] [Full Text] [Related]

  • 7. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
    Kim YK, Lee YH, Kwak HS, Kim CS, Han YM.
    Clin Imaging; 2008 Dec; 32(6):453-9. PubMed ID: 19006774
    [Abstract] [Full Text] [Related]

  • 8. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS, Hong SI, Park SY, Son Y, Lee YS, Chung YH, Yang SK, Suh DJ, Min YI.
    Anticancer Res; 1995 Dec; 15(6B):2777-80. PubMed ID: 8669863
    [Abstract] [Full Text] [Related]

  • 9. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
    Huo TI, Hsia CY, Chu CJ, Huang YH, Lui WY, Wu JC, Lee PC, Chi CW, Lee SD.
    J Surg Oncol; 2007 Jun 15; 95(8):645-51. PubMed ID: 17530668
    [Abstract] [Full Text] [Related]

  • 10. Outcomes of patients with elevated α-fetoprotein level and initial negative findings at MR imaging.
    Kim BS, Hayashi PH, Kim SH, Angthong W, Srirattanapong S, Woosley JT, Semelka RC.
    Radiology; 2013 Jul 15; 268(1):109-19. PubMed ID: 23392426
    [Abstract] [Full Text] [Related]

  • 11. Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study.
    Izuno K, Fujiyama S, Yamasaki K, Sato M, Sato T.
    Hepatogastroenterology; 1995 Jul 15; 42(4):387-93. PubMed ID: 8586374
    [Abstract] [Full Text] [Related]

  • 12. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS, Park JW, Jang JS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.
    J Clin Gastroenterol; 2009 Jul 15; 43(5):482-8. PubMed ID: 19197197
    [Abstract] [Full Text] [Related]

  • 13. MR imaging in diffuse-type hepatocellular carcinoma with synchronous portal vein thrombi.
    Halıloğlu N, Özkavukcu E, Erden A, Erden İ.
    Turk J Gastroenterol; 2011 Jul 15; 22(2):158-64. PubMed ID: 21796552
    [Abstract] [Full Text] [Related]

  • 14. Serum ferritin in hepatocellular carcinoma.
    Zhou XD, Stahlhut MW, Hann HL, London WT.
    Hepatogastroenterology; 1988 Feb 15; 35(1):1-4. PubMed ID: 2452122
    [Abstract] [Full Text] [Related]

  • 15. [Differential diagnosis between hepatic focal nodular hyperplasia and hepatocellular carcinoma with negative alhpa-fetoprotein].
    Ye Q, Tang Z, Ma Z, Wu Z, Fan J, Qin L, Wang W.
    Zhonghua Gan Zang Bing Za Zhi; 2000 Jun 15; 8(3):136-8. PubMed ID: 10880157
    [Abstract] [Full Text] [Related]

  • 16. Imaging of benign hypervascular hepatocellular nodules in alcoholic liver cirrhosis: differentiation from hypervascular hepatocellular carcinoma.
    Kobayashi S, Matsui O, Kamura T, Yamamoto S, Yoneda N, Gabata T, Terayama N, Sanada J.
    J Comput Assist Tomogr; 2007 Jun 15; 31(4):557-63. PubMed ID: 17882031
    [Abstract] [Full Text] [Related]

  • 17. Stepwise carcinogenesis of hepatocellular carcinoma in the cirrhotic liver: demonstration on serial MR imaging.
    van den Bos IC, Hussain SM, Terkivatan T, Zondervan PE, de Man RA.
    J Magn Reson Imaging; 2006 Nov 15; 24(5):1071-80. PubMed ID: 17024654
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, Carroccio A, Sesti R, Tripi S, Montalto G.
    Anticancer Res; 2003 Nov 15; 23(2C):1747-53. PubMed ID: 12820452
    [Abstract] [Full Text] [Related]

  • 19. Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis.
    Henry L, Lavabre-Bertrand T, Vercambre L, Ramos J, Carillo S, Guiraud I, Pouderoux P, Bismuth M, Valats JC, Demattei C, Duny Y, Chaze I, Funakoshi N, Bureau JP, Daurès JP, Blanc P.
    Gut; 2009 Jun 15; 58(6):833-8. PubMed ID: 19201777
    [Abstract] [Full Text] [Related]

  • 20. Fibrolamellar carcinoma of the liver with a mixture of ordinary hepatocellular carcinoma: a case report.
    Okano A, Hajiro K, Takakuwa H, Kobashi Y.
    Am J Gastroenterol; 1998 Jul 15; 93(7):1144-5. PubMed ID: 9672347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.